As artificial intelligence (AI) continues to integrate into dermatology, it’s important to not only ask how doctors are using it, but also how patients perceive it. One popular way AI is being used in dermatology is through skin cancer screening. […]
Patients Prefer AI in Skin Cancer Screening as an Assistive Tool, Not a Replacement Read More »
In an interview with The American Journal of Managed Care® (AJMC®), Douglas Flora, MD, FACCC, executive medical director of oncology services at St. Elizabeth Healthcare, and editor in chief of AI in Precision Oncology, discussed how artificial intelligence (AI) can expedite
Using AI to Screen for Cancers Now May Boost Survival Down the Road Read More »
Five years after the initial wave of COVID-19, its long-term effects continue to impact patient recovery, particularly for those with severe infections, cancer histories, or limited health care access. While COVID-19 is no longer an active public health emergency, it
Studies Highlight Lingering Risks and Disparities of Long COVID Read More »
In a survey of more than 1000 Americans, nearly three-quarters gave the US health care system a grade of C or lower, highlighting widespread dissatisfaction with costs, access, and government regulation.1 Only half of respondents reported being able to afford
Americans Give US Health Care System a C Grade, Calling for Policy Change Read More »
Artificial intelligence (AI) has taken the country by storm in recent years, especially in the health care space. During the Association of Cancer Care Centers (ACCC) 51st Annual Meeting & Cancer Center Business Summit in Washington, DC, Douglas Flora, MD,
AI Is Not Going “Back in Pandora’s Box” in Cancer Care Read More »
At the Association of Cancer Care Centers (ACCC) 51st Annual Meeting & Cancer Center Business Summit in Washington, DC, Jorge García, PharmD, MS, MBA, MHA, FACHE, FACCC, reflects on his experience at ACCC Capitol Hill Day, where discussions with policy
On Capitol Hill, Experts Discuss Health Policy, PBMs, Drug Shortages, and More Read More »
The FDA approved the label expansion for furosemide injection (Furoscix; scPharmaceuticals) to treat edema caused by fluid buildup in patients with chronic kidney disease (CKD).1 Last year, the drug developer noted that FDA feedback from a 2023 Type D meeting
FDA Expands Furosemide Injection Label to Treat Edema in CKD Read More »
Ibrutinib remains a key treatment for relapsed or refractory (R/R) chronic lymphocytic leukemia (CLL), but combining it with other therapies can significantly enhance patient outcomes, according to new research.1 A meta-analysis published in BMC Pharmacology and Toxicology included data from
Ibrutinib Benefits R/R CLL, but Combo Therapy Works Better Read More »
The House of Representatives passed a budget resolution (H Con Res 14, 119th Congress) that includes deep cuts to Medicaid, advancing the Republican-led plan in a 217-215 vote Tuesday evening.1 If the resolution becomes law, states could be forced to
House Passes Budget Resolution Cutting Billions From Medicaid Funding Read More »
During an Institute for Value-Based Medicine event in November 2024, experts in oncology highlighted how insurance coverage disparities and financial burdens limit equitable cancer care. In this interview, Susan Escudier, MD, FACP, medical oncologist and vice president of value-based care
The Need for Payer Support in Overcoming Cancer Care Disparities Read More »
